PVG.L Regulatory News (PVG)

PREMIER VETERINARY GROUP PLC

("PVG" or the "Company")

Capital Reduction

Premier Veterinary Group plc announces that, further to a resolution passed by Shareholders at the Annual General Meeting held on 23 March 2016, in order to facilitate the proposed reduction of PVG's share capital (the "Capital Reduction"), full details of which were set out in the Notice of Annual General Meeting dated 28 January 2016 (the "Notice"), the Company has today issued and allotted 1,690,315 deferred shares of 90 pence each (the "Deferred Shares") to Sue Steven, the Secretary of the Company.

The deferred shares do not entitle holders to receive notice of or attend and vote at any general meeting of the Company or to receive a dividend or other distribution or to participate in any return on capital on a winding up other than the nominal amount paid on such shares following a substantial distribution to the holders of ordinary shares in the Company. Accordingly, the deferred shares are, for all practical purposes, valueless.

As set out in the Notice, the share capital of the Company will be reduced by cancelling and extinguishing both the Deferred Shares together with all other deferred shares of 90 pence each in the capital of the Company on 30 August 2016.

The Company is in the process of making an application to the High Court of Justice, Chancery Division, for approval for the reduction of PVG's share capital and cancellation of the entire amount standing to the credit of the Company's share premium account.

A further announcement will be issued in due course.

For further information, please contact:

Premier Veterinary Group plc Tel: +44 (0)117 970 4130

Dominic Tonner, Chief Executive Officer

Daniel Smith, Chief Financial Officer

Zeus Capital Limited Tel: +44 (0)203 829 5000

Giles Balleny, Director, Corporate Finance

Hugh Kingsmill Moore, Director, Sales 

Square1 Consulting Tel: +44 (0)207 929 5599

David Bick/Brian Alexander